您的当前位置:首页 > 行业数据 > Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups
图片属性
图片格式:PNG 图片大小:109KB 图片尺寸:1170*609
同报告图片
 / 4
Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups_第1页
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
Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups_第2页
Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups_第3页
Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups_第4页
Long-Term CARTITUDE-4 Update (34 Months): Consistent Progression-Free Survival Benefit for Cilta-cel Across All Prespecified Subgroups_第5页
所属报告: 传奇生物Legend Biotech(LEGN)2025年20-F年度报告「NASDAQ」(英文版)(720页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠